Unknown

Dataset Information

0

Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.


ABSTRACT: Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease with progressive fibrosis and death within 2-3 y of diagnosis. IPF incidence and prevalence rates are increasing annually with few effective treatments available. Inhibition of IL-6 results in the attenuation of pulmonary fibrosis in mice. It is unclear whether this is due to blockade of classical signaling, mediated by membrane-bound IL-6Rα, or trans signaling, mediated by soluble IL-6Rα (sIL-6Rα). Our study assessed the role of sIL-6Rα in IPF. We demonstrated elevations of sIL-6Rα in IPF patients and in mice during the onset and progression of fibrosis. We demonstrated that protease-mediated cleavage from lung macrophages was important in production of sIL-6Rα. In vivo neutralization of sIL-6Rα attenuated pulmonary fibrosis in mice as seen by reductions in myofibroblasts, fibronectin, and collagen in the lung. In vitro activation of IL-6 trans signaling enhanced fibroblast proliferation and extracellular matrix protein production, effects relevant in the progression of pulmonary fibrosis. Taken together, these findings demonstrate that the production of sIL-6Rα from macrophages in the diseased lung contributes to IL-6 trans signaling that in turn influences events crucial in pulmonary fibrosis.

SUBMITTER: Le TT 

PROVIDER: S-EPMC4169999 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2020-12-23 | GSE163740 | GEO
| S-EPMC8326405 | biostudies-literature
| S-EPMC8365894 | biostudies-literature
| PRJNA687400 | ENA
| S-EPMC2213091 | biostudies-literature
| S-EPMC9133504 | biostudies-literature
| S-EPMC5385413 | biostudies-literature
| S-EPMC7587452 | biostudies-literature
2015-01-15 | E-GEOD-65011 | biostudies-arrayexpress
| S-EPMC8395032 | biostudies-literature